|
Characteristics of the studied populations |
||
| AIMS data (± SD) |
EOC data (± SD) |
|
|
|
||
| N |
340 |
92 |
| Sex (% of males) |
58.2 |
45.6 |
| Age (y) |
63.5 ± 14.6 |
69.7 ± 12.1 |
| Weight (kg) |
69.5 ± 15.3 |
69.9 ± 15.4 |
| Diabetes mellitus (%) |
27.4 |
34.7 |
| Cardiomyopathy (%) |
16.5 |
13.0a |
| ACE-I or ARB treatment (%) |
No data |
89.1 |
| Haemoglobin g/dLb |
11.8 ± 1.4 |
11.6 ± 0.7 |
| Creatinine μmol/Lb |
580 ± 156 |
552 ± 145 |
| BUN mmol/Lb |
No data |
24.6 ± 6.0 |
| Kt/V |
No data |
1.33 ± 0.26 |
| pHb |
No data |
7.36 ± 0.04 |
| Phosphate mmol/Lb |
No data |
2.00 ± 1.38 |
| Ionized calcium mmol/Lb |
No data |
1.20 ± 0.07 |
| Albumin g/Lb |
No data |
37.9 ± 2.9 |
| Ferritin mg/mL |
411 ± 297 |
482 ± 255 |
| PTH pmol/L |
No data |
25.8 ± 21.9 |
| CRP mg/Lb |
No data |
15.7 ± 15.8 |
| Iron intravenously mg/month |
No data |
134 ± 50 |
| Epoetin beta dose IU/Kg/week to reach a haemoglobin of 11.5 g/dL |
149 ± 104 |
107 ± 63 |
| Epoetin administration route % of subcutaneous |
71 |
0 |
|
a only patients with a left ventricular ejection fraction <50%; b pre-dialysis values Anthropometric data, comorbidity incidence, ACE-I or ARB treatment and mean results of the monthly biochemical parameters of the AIMS and EOC data pools. | ||
Gabutti et al. BMC Nephrology 2006 7:13 doi:10.1186/1471-2369-7-13 |
||